Association Between Prolactin Levels in Pregnant Women to- 2 Gether With Rates of Breastfeeding and the Covid-19 Virus
Sponsor
Universidad Católica de Ávila (Other)
Overall Status
Completed
CT.gov ID
NCT05506280
Collaborator
(none)
720
1
1.3
561.9
Study Details
Study Description
Brief Summary
(1) Background: Currently in the world, 41% of children under 6 months are exclusively 13 breastfed. The Covid-19 pandemic has had a major impact on breastfeeding.; (2) Methods: A statis- 14 tical analysis of linear regression, prolactin analysis in the 3rd trimester of pregnancy and 15 days 15 after delivery was performed in women with Covid- 19 infection and healthy, finally the rates of 16 breastfeeding were evaluated. The sample was made up of 680 pregnant women from the Valladolid 17 Health Area, central region of Spain.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
720 participants
Observational Model:
Other
Time Perspective:
Retrospective
Official Title:
Association Between Prolactin Levels in Pregnant Women to- 2 Gether With Rates of Breastfeeding and the Covid-19 Virus. A 3 Randomised Trial
Actual Study Start Date
:
Apr 13, 2022
Actual Primary Completion Date
:
Apr 30, 2022
Actual Study Completion Date
:
May 22, 2022
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Pregnant women pregnant women infected by Covid-19 |
Procedure: blood prolactin levels
The extraction technique was performed by venipuncture in 110 veins located in the antecubital area with a 21G butterfly nut with a Vacutainer Safety 111 Lok@ adapter, a 2.5x45cm latex venous compressor and a tube with separating gel 112 (yellow cap)
|
Outcome Measures
Primary Outcome Measures
- higher average value of prolactin [15 days]
ng/ml. 0 mimimun, 100 maximum
Eligibility Criteria
Criteria
Ages Eligible for Study:
16 Years
to 50 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- pregnant women under the coding of the clinical process of normal pregnancy or diagnosis of Covid-19 infection
Exclusion Criteria:
-
No informed consent.
-
No pregnant women.
-
Older than 50 years old.
-
Younger than 16 years old.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Universidad Católica de Ávila | Ávila | Spain | 05005 |
Sponsors and Collaborators
- Universidad Católica de Ávila
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
Responsible Party:
JORGE VELAZQUEZ SAORNIL,
Principal Investigator,
Universidad Católica de Ávila
ClinicalTrials.gov Identifier:
NCT05506280
Other Study ID Numbers:
- 16/08/22
First Posted:
Aug 18, 2022
Last Update Posted:
Aug 18, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by JORGE VELAZQUEZ SAORNIL,
Principal Investigator,
Universidad Católica de Ávila
Additional relevant MeSH terms: